Biology subjects

Baran, A. M.

Publications and source records attributed to Baran, A. M..

4 recordsLinked to original sources

bioRxiv2026

An assessment of normalization and differential expression methods for miRNA-seq analysis using a realistic benchmark dataset

MicroRNAs are short noncoding RNAs that regulate gene expression and are commonly profiled by small RNA sequencing (miRNA-seq). Despite the widespread use of miRNA-seq, datasets are often analyzed with RNA-seq method such as DESeq2 or edgeR, which do not take into account the specific characteristics of miRNA-seq data. Here, we present a benchmark study of normalization and differential expression approaches using a realistic ground-truth dataset. By mixing mouse RNA of two organs, we generated expression trends while capturing biological and technical variability. Using monotonicity across the dataset and expected fold changes from the mixture design, we assessed normalization and differential expression methods. Normalization benchmarking showed that within-sample scaling, particularly Read Per Million (RPM), best preserved the expected monotonic trends, outperforming cross-sample methods such as TMM, rlog, and VST. These approaches sometimes recovered apparent monotonicity among abundant miRNAs, but inspection of individual profiles suggested likely over-correction. Regarding differential expression, edgeR consistently ranked among the best-performing methods across several metrics, including log2 fold-change estimation, with performance comparable to miRNA-seq-specific tools such as miRglmm and NBSR. DESeq2, edgeR-v4, and limma-based approaches tended to systematically underestimate log2 fold changes. Applying a common RPM-based normalization substantially improved the performance of cross-sample methods, highlighting the strong influence of normalization on differential expression analysis. Overall, our findings support within-sample scaling methods such as RPM for normalization, and edgeR, miRglmm, or NBSR for differential expression. The dataset has been made publicly available, providing a valuable resource for objective method comparison and future miRNA-seq software development.

bioinformatics↗

bioRxiv2026

PARiS: Probabilistic Assignment and Repartitioning of isomiR Sequences: A data-driven method for denoising isomiR read count data

MicroRNAs (miRNAs) are non-coding RNAs, approximately 18-24 nucleotides in length, with important gene regulatory functions. In small RNA sequencing (sRNA-seq), observed isoforms of miRNA, called isomiRs, arise from my biological and technical processes. Alterations in isomiR expression has been linked to a wide variety of human diseases, from cancers to neurological diseases. However, it is difficult to distinguish between technical and biological isomiRs. We present PARiS, an algorithm for the Probabilistic Assignment and Repartitioning of isomiR Sequences, that identifies technical error isomiRs in sRNA-seq data and reassigns them to their most likely biological source. We assess the ability of PARiS to identify and remove error isomiR sequences in a realistic simulation study. Additionally, we compare PARiS to alternative approaches, focusing on downstream miRNA-level differential expression analysis in a variety of settings, including a set of simulated datasets, an experimental benchmark dataset, and three colorectal adenocarcinoma cell lines.

bioinformatics↗

bioRxiv2024

miRglmm: a generalized linear mixed model of isomiR-level counts improves estimation of miRNA level differential expression and uncovers variable differential expression between isomiRs

MicroRNA-seq data is produced by aligning small RNA sequencing reads of different miRNA transcript isoforms, called isomiRs, to known microRNAs. Aggregation to microRNA-level counts discards information and violates core assumptions of differential expression (DE) methods developed for mRNA-seq data. We establish miRglmm, a DE method for microRNA-seq data, that uses a generalized linear mixed model of isomiR-level counts, facilitating detection of miRNA with differential expression or differential isomiR usage. We demonstrate that miRglmm outperforms current DE methods in estimating DE for miRNA, whether or not there is significant isomiR variability, and simultaneously provides estimates of isomiR-level DE.

bioinformatics↗

bioRxiv2021

Gene Expression Risk Scores for COVID-19 Illness Severity

BackgroundThe correlates of COVID-19 illness severity following infection with SARS-Coronavirus 2 (SARS-CoV-2) are incompletely understood. MethodsWe assessed peripheral blood gene expression in 53 adults with confirmed SARS-CoV-2-infection clinically adjudicated as having mild, moderate or severe disease. Supervised principal components analysis was used to build a weighted gene expression risk score (WGERS) to discriminate between severe and non-severe COVID. ResultsGene expression patterns in participants with mild and moderate illness were similar, but significantly different from severe illness. When comparing severe versus non-severe illness, we identified >4000 genes differentially expressed (FDR<0.05). Biological pathways increased in severe COVID-19 were associated with platelet activation and coagulation, and those significantly decreased with T cell signaling and differentiation. A WGERS based on 18 genes distinguished severe illness in our training cohort (cross-validated ROC-AUC=0.98), and need for intensive care in an independent cohort (ROC-AUC=0.85). Dichotomizing the WGERS yielded 100% sensitivity and 85% specificity for classifying severe illness in our training cohort, and 84% sensitivity and 74% specificity for defining the need for intensive care in the validation cohort. ConclusionThese data suggest that gene expression classifiers may provide clinical utility as predictors of COVID-19 illness severity.

genomics↗